BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 15908752)

  • 1. Long-term outcome of patients with antineutrophil cytoplasmic autoantibody-associated vasculitis with renal involvement.
    Rihova Z; Jancova E; Merta M; Rysava R; Reiterova J; Zabka J; Tesar V
    Kidney Blood Press Res; 2005; 28(3):144-52. PubMed ID: 15908752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ANCA-associated renal vasculitis at the end of the twentieth century--a disease of older patients.
    Harper L; Savage CO
    Rheumatology (Oxford); 2005 Apr; 44(4):495-501. PubMed ID: 15613403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ANCA-associated vasculitis with renal involvement: an outcome analysis.
    Weidner S; Geuss S; Hafezi-Rachti S; Wonka A; Rupprecht HD
    Nephrol Dial Transplant; 2004 Jun; 19(6):1403-11. PubMed ID: 15069175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study.
    Booth AD; Almond MK; Burns A; Ellis P; Gaskin G; Neild GH; Plaisance M; Pusey CD; Jayne DR;
    Am J Kidney Dis; 2003 Apr; 41(4):776-84. PubMed ID: 12666064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive classic antineutrophil cytoplasmic antibody (C-ANCA) titer at switch to azathioprine therapy associated with relapse in proteinase 3-related vasculitis.
    Slot MC; Tervaert JW; Boomsma MM; Stegeman CA
    Arthritis Rheum; 2004 Apr; 51(2):269-73. PubMed ID: 15077271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up.
    Harper L; Morgan MD; Walsh M; Hoglund P; Westman K; Flossmann O; Tesar V; Vanhille P; de Groot K; Luqmani R; Flores-Suarez LF; Watts R; Pusey C; Bruchfeld A; Rasmussen N; Blockmans D; Savage CO; Jayne D;
    Ann Rheum Dis; 2012 Jun; 71(6):955-60. PubMed ID: 22128076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome analysis of patients with vasculitis associated with antineutrophil cytoplasmic antibodies.
    Brijker F; Magee CC; Tervaert JW; O'Neill S; Walshe JJ
    Clin Nephrol; 1999 Dec; 52(6):344-51. PubMed ID: 10604641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort.
    Comarmond C; Pagnoux C; Khellaf M; Cordier JF; Hamidou M; Viallard JF; Maurier F; Jouneau S; Bienvenu B; Puéchal X; Aumaître O; Le Guenno G; Le Quellec A; Cevallos R; Fain O; Godeau B; Seror R; Dunogué B; Mahr A; Guilpain P; Cohen P; Aouba A; Mouthon L; Guillevin L;
    Arthritis Rheum; 2013 Jan; 65(1):270-81. PubMed ID: 23044708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histological and clinical predictors of early and late renal outcome in ANCA-associated vasculitis.
    Neumann I; Kain R; Regele H; Soleiman A; Kandutsch S; Meisl FT
    Nephrol Dial Transplant; 2005 Jan; 20(1):96-104. PubMed ID: 15546891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.
    De Groot K; Rasmussen N; Bacon PA; Tervaert JW; Feighery C; Gregorini G; Gross WL; Luqmani R; Jayne DR
    Arthritis Rheum; 2005 Aug; 52(8):2461-9. PubMed ID: 16052573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies.
    Jayne D; Rasmussen N; Andrassy K; Bacon P; Tervaert JW; Dadoniené J; Ekstrand A; Gaskin G; Gregorini G; de Groot K; Gross W; Hagen EC; Mirapeix E; Pettersson E; Siegert C; Sinico A; Tesar V; Westman K; Pusey C;
    N Engl J Med; 2003 Jul; 349(1):36-44. PubMed ID: 12840090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of damage and survival in patients with Wegener's granulomatosis: analysis of 50 patients.
    Kamali S; Erer B; Artim-Esen B; Gul A; Ocal L; Konice M; Aral O; Inanc M
    J Rheumatol; 2010 Feb; 37(2):374-8. PubMed ID: 20008921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [ANCA-associated vasculitis].
    Sinico RA; Sabadini E; Boeri R; Radice A
    G Ital Nefrol; 2002; 19(2):125-36. PubMed ID: 12195410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relapses in patients with a systemic vasculitis.
    Gordon M; Luqmani RA; Adu D; Greaves I; Richards N; Michael J; Emery P; Howie AJ; Bacon PA
    Q J Med; 1993 Dec; 86(12):779-89. PubMed ID: 7906421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and pathological characteristics and outcomes of Chinese patients with primary anti-neutrophil cytoplasmic antibodies-associated systemic vasculitis with immune complex deposition in kidney.
    Yu F; Chen M; Wang SX; Zou WZ; Zhao MH; Wang HY
    Nephrology (Carlton); 2007 Feb; 12(1):74-80. PubMed ID: 17295665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propylthiouracil-associated antineutrophil cytoplasmic autoantibody-positive vasculitis: retrospective study of 19 cases.
    Chen YX; Yu HJ; Ni LY; Zhang W; Xu YW; Ren H; Chen XN; Wang XL; Li X; Pan XX; Wang WM; Chen N
    J Rheumatol; 2007 Dec; 34(12):2451-6. PubMed ID: 17985400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brief Report: long-term outcome of a randomized clinical trial comparing methotrexate to cyclophosphamide for remission induction in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.
    Faurschou M; Westman K; Rasmussen N; de Groot K; Flossmann O; Höglund P; Jayne DR;
    Arthritis Rheum; 2012 Oct; 64(10):3472-7. PubMed ID: 22614882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrences and infections during continuous immunosuppressive therapy after beginning dialysis in ANCA-associated vasculitis.
    Weidanz F; Day CJ; Hewins P; Savage CO; Harper L
    Am J Kidney Dis; 2007 Jul; 50(1):36-46. PubMed ID: 17591523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pauci-immune renal vasculitis: natural history, prognostic factors, and impact of therapy.
    Cohen BA; Clark WF
    Am J Kidney Dis; 2000 Nov; 36(5):914-24. PubMed ID: 11054347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal survival and prognostic factors in patients with PR3-ANCA associated vasculitis with renal involvement.
    Slot MC; Tervaert JW; Franssen CF; Stegeman CA
    Kidney Int; 2003 Feb; 63(2):670-7. PubMed ID: 12631133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.